A new Elsevier book edited by Dr. Vahid Mansouri and Dr. Maryam Bemanalizadeh explores gene therapy approaches for neurodegenerative and neuromuscular disorders, from delivery technologies to clinical translation.
Three abstracts involving members of the Exir Gene Pharmed team were presented at the 2026 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) in Boston.
A long-term preclinical study by members of our scientific team evaluated the safety and sustained transgene expression of systemic AAV9-mediated SMN1 gene delivery in neonatal mice.
Research by members of the Exir Gene Pharmed team was presented at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) in New Orleans in May 2025.
